Evidence map›Paper›PMID 36495270›Full record

ArticleBritish journal of pharmacology2023

Kinetic analysis of endogenous β

Sean A Cullum, Dmitry B Veprintsev, Stephen J Hill

Open access · hybridAbstract read
In one paragraph

Article in British journal of pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Class A and B GPCRs trigger rapid GαCommunications biology · 2025
    Article
  7. A Chemically Stable Photocaged Noradrenaline.ACS chemical neuroscience · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Kinetic analysis of endogenous βBritish journal of pharmacology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sean A CullumDivision of Physiology, Pharmacology and Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, UK.
Dmitry B VeprintsevDivision of Physiology, Pharmacology and Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, UK.
Stephen J HillDivision of Physiology, Pharmacology and Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, UK.ORCID 0000-0002-4424-239X
University of Nottingham · GB

Funding

Medical Research Council G0800006Medical Research Council MR/N013913/1Medical Research Council MR/N020081/1
6 · The paper itself

Abstract

BACKGROUND AND

aimStandard pharmacological analysis of agonist activity utilises measurements of receptor-mediated responses at a set time-point, or at the peak response level, to characterise ligands. However, the occurrence of non-equilibrium conditions may dramatically impact the properties of the response being measured. Here we have analysed the initial kinetic phases of cAMP responses to β EXPERIMENTAL APPROACH: The kinetics of β KEY

resultsThe partial agonists salbutamol and salmeterol displayed reduced relative IR CONCLUSIONS AND IMPLICATIONS: Kinetic analysis of real-time signalling data can provide valuable insights into the hemi-equilibria that can occur in low receptor reserve systems with agonist-antagonist interactions, due to incomplete dissociation of antagonist whilst the peak agonist response is developing.

Indexed as

Adrenergic beta-AgonistsBisoprololAdrenergic beta-AntagonistsCyclic AMPHEK293 CellsHumansIsoproterenolKineticsReceptors, Adrenergic, beta-2Adrenergic beta-AgonistsAdrenergic beta-AntagonistsBisoprololCyclic AMPIsoproterenolReceptors, Adrenergic, beta-2analytical pharmacologycAMPsignalling kineticsβ2-adrenoceptor

Identifiers

PMID36495270
PMCPMC10952559
OpenAlexW4311023377

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.